What is the effect of Lysoveta DHA-LPC for APOE4 carriers?
Phoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Browse by intervention
One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsPhoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
| Outcome | Direction | What we observed |
|---|---|---|
| Triglycerides | Positive individual result | Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days. |
Too early to say. In mice, DHA given as LPC-DHA reaches the brain far better than free DHA, but another mouse study in APOE4 mice did not see this, and no human trial has tested LPC-DHA on brain DHA or memory. Fatty fish and a tested omega-3 index remain the measurable basics.
APOE4-specific evidence: limited
Too early to say: LPC-DHA reaches the brain better in some mouse studies but not others, and there is no human evidence yet that it protects memory.
Nguyen 2014, Nature
Animal or lab study
Animal and cell study: the brain's DHA door, Mfsd2a, carries DHA in the LPC form.
Read on PubMed (opens in a new tab)Sugasini 2017, Sci RepGrade D
Animal or lab study
Animal study: in mice, DHA given as LPC-DHA more than doubled brain DHA; the same dose of free DHA did not.
Read on PubMed (opens in a new tab)Scheinman 2021, Front NeurosciGrade D
Animal or lab study
Animal study: in APOE4 mice, an LPC-enriched krill oil raised hippocampal DHA.
Read on PubMed (opens in a new tab)Andriambelo 2025, Prostaglandins Leukot Essent Fatty AcidsGrade D
Animal or lab study
Animal study: LPC-bound omega-3 raised cortex EPA but not DHA, and in APOE4 mice moved neither at two months.
Read on PubMed (opens in a new tab)Yassine 2017, Alzheimers Res Ther
PET study of 22 adults: APOE4 carriers took DHA into the brain about 16% faster than non-carriers.
Read on PubMed (opens in a new tab)Arellanes 2020, EBioMedicine
Randomized trial: high-dose DHA raised spinal-fluid DHA 28%; the EPA rise in non-carriers was three times that of APOE4 carriers; no change in memory over 6 months.
Read on PubMed (opens in a new tab)Sydenham 2012, Cochrane Database Syst Rev
Omega-3 supplements did not improve thinking in healthy older adults over trials of up to 3.5 years.
Read on PubMed (opens in a new tab)7 passages for, 1 with a caution, 1 also discussed
Now showing: Dr. Kevin Tran · 5:09
Open on YouTube (opens in a new tab)
For the brain, DHA form matters more than dose.
“For your heart, it is how much. For your apoE4 brain, it is which form.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

Only LPC-DHA fits the brain's DHA door.
“it only carries DHA in one form, lysophosphatidylcholine, LPC-DHA for short.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

In mice, LPC-DHA doubled brain DHA; free DHA did not.
“30 days later, as LPC-DHA brain DHA more than doubled. As free DHA, it did not move at all.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

Kevin takes LPC-DHA from a Phoenix partner; he discloses it.
“I take an omega-3 from what is called Accentrate Omega Max LPC-DHA made by Phoenix Health Science.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

LPC-DHA uses a different door into the brain.
“use a completely different transporter called the MFSD2A that's on the inner membrane of the BBB.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

LPC-DHA looks best for the brain; human data pending.
Dr. Kevin Tran
Watch the Short on YouTube (opens in a new tab)
The form of DHA may matter for the brain; human trials are still pending.
Dr. Kevin Tran
Watch the Short on YouTube (opens in a new tab)
LPC-DHA evidence is from mice so far.
“this is, of course, animal data, not human cognition data, and the human trial in carriers is still pending.”
Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier
Whether LPC-DHA reaches the brain is unsettled.
“The manufacturer data showed that it looked as though it got into the brain. Another study looking at it seems to indicate that it doesn't.”
Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier
Last reviewed
Phoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
Want to try Lysoveta DHA-LPC and see whether it works for you? Phoenix tracks it beside your labs and how you feel.
Apply to join PhoenixLysoveta DHA-LPC · 1 outcome shown.
Triglycerides: Decrease 28.7 mg/dL
Cases: 1
Lysoveta DHA-LPC
✓Positive individual resultMember #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Triglycerides
Before81After52.3mg/dL-35.4%
106 days between measurements
Full stack credited: Lysoveta (DHA-LPC) (lead), Curcumin (co), Nicotinamide riboside (co).
What else changed: no nearby starts were recorded.
Next study: repeat Triglycerides after a dated Lysoveta DHA-LPC window.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.